Kyprolis (carfilzomib) for Injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
January 2016
WARNINGS AND PRECAUTIONS
Cardiac Toxicities
…These patients may be at greater risk for cardiac complications and...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts